Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lovejoy

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Molecular Pharmacology|July 8, 2010
Membrane transport and intracellular sequestration of novel thiosemicarbazone chelators for the treatment of cancerAngelica M Merlot, Namfon Pantarat, David B Lovejoy, et al.
Science (New York, N.Y.)|February 26, 1993
Crystal structure of a synthetic triple-stranded alpha-helical bundleB Lovejoy, S Choe, D Cascio, et al.
Biochimica Et Biophysica Acta|May 20, 2008
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agentsD R Richardson, D S Kalinowski, S Lau, et al.
British Journal of Pharmacology|March 19, 2003
Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agentsErika M Becker, David B Lovejoy, Judith M Greer, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|June 1, 1979
Effects of chronic amorphous silica exposure on sequential pulmonary functionR K Wilson, P M Stevens, H B Lovejoy, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 23, 2008
HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agentsJán Stariat, Petra Kovaríková, Jirí Klimes, et al.
Oncotarget|December 10, 2015
Understanding the role of the kynurenine pathway in human breast cancer immunobiologyBenjamin Heng, Chai K Lim, David B Lovejoy, et al.
Current Drug Delivery|May 29, 2010
Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour ActivityZ Kovacevic, D S Kalinowski, D B Lovejoy, et al.
Cancer Research|July 14, 2011
Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomesDavid B Lovejoy, Patric J Jansson, Ulf T Brunk, et al.
Complex Psychiatry|February 10, 2022
Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric DisordersMichael Y Bai, David B Lovejoy, Gilles J Guillemin, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Molecular Pharmacology|July 8, 2010
Membrane transport and intracellular sequestration of novel thiosemicarbazone chelators for the treatment of cancerAngelica M Merlot, Namfon Pantarat, David B Lovejoy, et al.
Science (New York, N.Y.)|February 26, 1993
Crystal structure of a synthetic triple-stranded alpha-helical bundleB Lovejoy, S Choe, D Cascio, et al.
Biochimica Et Biophysica Acta|May 20, 2008
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agentsD R Richardson, D S Kalinowski, S Lau, et al.
British Journal of Pharmacology|March 19, 2003
Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agentsErika M Becker, David B Lovejoy, Judith M Greer, et al.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|June 1, 1979
Effects of chronic amorphous silica exposure on sequential pulmonary functionR K Wilson, P M Stevens, H B Lovejoy, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 23, 2008
HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agentsJán Stariat, Petra Kovaríková, Jirí Klimes, et al.
Oncotarget|December 10, 2015
Understanding the role of the kynurenine pathway in human breast cancer immunobiologyBenjamin Heng, Chai K Lim, David B Lovejoy, et al.
Current Drug Delivery|May 29, 2010
Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour ActivityZ Kovacevic, D S Kalinowski, D B Lovejoy, et al.
Cancer Research|July 14, 2011
Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomesDavid B Lovejoy, Patric J Jansson, Ulf T Brunk, et al.
Complex Psychiatry|February 10, 2022
Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric DisordersMichael Y Bai, David B Lovejoy, Gilles J Guillemin, et al.
Pageof 8